Bigul

SICAGEN INDIA LTD. - 533014 - Board to consider Dividend

Sicagen India Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on May 25, 2022, inter alia :1. To consider and approve the Audited financial results (both Standalone & Consolidated) of the Company for the quarter and year ended March 31, 2022.2. To consider and approve the Audited Financial Statements (both Standalone & Consolidated) of the Company for the year ended March 31, 2022.3. To consider and recommend Equity dividend (if any) for the financial year 2021-22.As intimated earlier vide the Company''s letter dated March 31, 2022, the trading window for dealing in the Company's equity shares by the Designated Persons and their immediate relatives will remain closed from April 01, 2022 till 48 hours after the declaration of Audited Financial Results for the quarter and the year ended March 31, 2022, as per Company''s Code of Conduct to regulate, monitor and report trading by insiders, read with SEBI (Prohibition of Insider Trading) Regulations, 2015.
18-05-2022
Bigul

SICAGEN INDIA LTD. - 533014 - Board Meeting Intimation for Considering Audited Financial Results For The Quarter And Year Ended 31St March 2022.

SICAGEN INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2022 ,inter alia, to consider and approve the Audited Financial Results and Audited Financial Statements for the year ended 31st March, 2022 and recommendation of Equity Dividend if any for the FY 2021-22.
18-05-2022
Bigul

SICAGEN INDIA LTD. - 533014 - Updates on Voluntary Open Offer

Saffron Capital Advisors Pvt. Ltd. ("Manager to the Offer") has submitted to BSE a copy of Draft Letter of Offer to the Equity Shareholders of Sicagen India Ltd ("Target Company").
13-05-2022
Bigul

SICAGEN INDIA LTD. - 533014 - Updates on Voluntary Open Offer

Saffron Capital Advisors Pvt. Ltd. ("Manager to the Offer") has submitted to BSE a copy of Detailed Public Statement in terms of Regulation 6 read with 13(4), 14(3) and 15(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 to the Equity Shareholders of Sicagen India Ltd ("Target Company").
06-05-2022
Bigul

SICAGEN INDIA LTD. - 533014 - Voluntary Open Offer

Saffron Capital Advisors Pvt. Ltd. ("Manager to the Offer") Public Announcement for the attention of the Public Shareholders of Sicagen India Ltd ("Target Company") under Regulation 6 read with 13(2A) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and subsequent amendments thereof.
29-04-2022
Bigul

SICAGEN INDIA LTD. - 533014 - Compliances - Regulation 40 (10) Compliance Certificate For The Year Ended 31St March 2022

Pursuant to Regulation 40(10) of SEBI (LODR) Regulations, 2015, please find enclosed Compliance Certificate from Practicing Company Secretary for the year ended 31st March 2022.
22-04-2022
Bigul

SICAGEN INDIA LTD. - 533014 - Compliances - Compliance Certificate For The Year Ended 31St March 2022

Compliance certificate under Regulation 7(3) of SEBI (LODR) Regulations, 2015 for the year ended 31st March 2022 is attached.
13-04-2022
Bigul

SICAGEN INDIA LTD. - 533014 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Compliance certificate issued by Cameo Corporate Services Ltd (RTA) under Reg 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31st March 2022 is attached.
13-04-2022
Next Page
Close

Let's Open Free Demat Account